Zacks: Brokerages Expect CME Group Inc (CME) to Announce $1.60 EPS

Wall Street analysts forecast that CME Group Inc (NASDAQ:CME) will post earnings of $1.60 per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for CME Group’s earnings, with the lowest EPS estimate coming in at $1.54 and the highest estimate coming in at $1.74. CME Group posted earnings per share of $1.12 during the same quarter last year, which indicates a positive year-over-year growth rate of 42.9%. The business is expected to report its next quarterly earnings report on Thursday, February 7th.

On average, analysts expect that CME Group will report full year earnings of $6.65 per share for the current fiscal year, with EPS estimates ranging from $6.59 to $6.78. For the next financial year, analysts anticipate that the firm will post earnings of $7.24 per share, with EPS estimates ranging from $6.95 to $7.69. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that that provide coverage for CME Group.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, October 25th. The financial services provider reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.03. The company had revenue of $904.20 million for the quarter, compared to analysts’ expectations of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%.

A number of equities research analysts have issued reports on CME shares. Deutsche Bank reiterated a “buy” rating and issued a $192.00 target price (up from $185.00) on shares of CME Group in a research note on Thursday, October 11th. Bank of America reissued a “buy” rating and set a $200.00 price target on shares of CME Group in a report on Monday, November 5th. Jefferies Financial Group raised their price target on CME Group to $203.00 and gave the company a “buy” rating in a report on Monday, October 8th. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a report on Saturday, August 18th. Finally, Berenberg Bank raised CME Group from a “hold” rating to a “buy” rating and set a $220.00 price target on the stock in a report on Tuesday. Four investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $190.23.

CME stock traded down $3.45 during mid-day trading on Tuesday, reaching $192.16. The company had a trading volume of 2,652,855 shares, compared to its average volume of 1,654,638. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.09 and a current ratio of 1.09. The stock has a market capitalization of $66.48 billion, a price-to-earnings ratio of 40.29, a PEG ratio of 2.27 and a beta of 0.49. CME Group has a one year low of $140.51 and a one year high of $197.08.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be issued a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date of this dividend is Friday, December 7th. CME Group’s dividend payout ratio (DPR) is 58.70%.

In related news, COO Julie Holzrichter sold 3,353 shares of CME Group stock in a transaction dated Tuesday, November 6th. The stock was sold at an average price of $186.71, for a total transaction of $626,038.63. Following the transaction, the chief operating officer now directly owns 45,627 shares of the company’s stock, valued at $8,519,017.17. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Julie Winkler sold 5,847 shares of CME Group stock in a transaction dated Friday, November 16th. The stock was sold at an average price of $195.01, for a total value of $1,140,223.47. Following the transaction, the insider now directly owns 24,255 shares in the company, valued at $4,729,967.55. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 29,419 shares of company stock worth $5,346,532. 0.43% of the stock is owned by corporate insiders.

A number of large investors have recently added to or reduced their stakes in the stock. Prime Capital Investment Advisors LLC increased its stake in CME Group by 282.5% in the 3rd quarter. Prime Capital Investment Advisors LLC now owns 765 shares of the financial services provider’s stock worth $130,000 after purchasing an additional 565 shares in the last quarter. Honkamp Krueger Financial Services Inc. purchased a new position in CME Group in the 3rd quarter worth about $132,000. Bbva Compass Bancshares Inc. purchased a new position in CME Group in the 3rd quarter worth about $134,000. Meeder Asset Management Inc. increased its stake in CME Group by 84.8% in the 2nd quarter. Meeder Asset Management Inc. now owns 789 shares of the financial services provider’s stock worth $129,000 after purchasing an additional 362 shares in the last quarter. Finally, Kaizen Advisory LLC increased its stake in CME Group by 151.9% in the 2nd quarter. Kaizen Advisory LLC now owns 816 shares of the financial services provider’s stock worth $134,000 after purchasing an additional 492 shares in the last quarter. 84.55% of the stock is currently owned by hedge funds and other institutional investors.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Recommended Story: How To Calculate Debt-to-Equity Ratio

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply